(Q34085913)

30 July 2017

1 reference

title

Hormonal preservation of bone in rheumatoid arthritis (English)

1 reference

30 July 2017

1 reference

Bijlsma JW

1

1 reference

PubMed ID

11084950

30 July 2017

Jacobs JW

series ordinal

2

1 reference

30 July 2017

1 November 2000

1 reference

Rheumatic Diseases Clinics of North America

30 July 2017

1 reference

30 July 2017

26

1 reference

30 July 2017

4

1 reference

30 July 2017

897-910

1 reference

Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone metabolism in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Prevention of glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

The neuroendocrine immune basis of rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Rheumatoid arthritis, corticosteroid therapy and hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. II. Bromsulphalein (BSP) retention and liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone mass measurement and bone metabolism in rheumatoid arthritis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

A randomized trial of testosterone therapy in males with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Fractures after rheumatoid arthritis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Osteoporosis associated with rheumatoid arthritis: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Rapid loss of vertebral mineral density after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Generalised and Localised Bone Loss in Patients with Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Methods to score vertebral deformities in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

1 reference

7 January 2021

Slow-release sodium fluoride in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Calcium supplements in the prevention of steroid-induced osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Longitudinal bone mineral density changes in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

1 reference

7 January 2021

Low free testosterone levels in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

Bone loss of the radius in rheumatoid arthritis. Comparison between 34 patients and 40 controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970175-7

7 January 2021

10.1016/S0889-857X(05)70175-7

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11084950